DEXCOM, INC. (DXCM) Total liabilities 2016–2025
DEXCOM, INC. (DXCM) total liabilities at each fiscal year-end, per SEC filings.
$3.6BFY2025 · since FY2016: $119.0M → $3.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.6B | -18.0% |
| FY2024 | $4.4B | +4.4% |
| FY2023 | $4.2B | +28.7% |
| FY2022 | $3.3B | +12.8% |
| FY2021 | $2.9B | +17.3% |
| FY2020 | $2.5B | +62.9% |
| FY2019 | $1.5B | +20.7% |
| FY2018 | $1.3B | +158.4% |
| FY2017 | $484.7M | +307.3% |
| FY2016 | $119.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice